---
title: Mm Bl
draft: true
---

## Summary
- 56M anesthesiologist (forced leave for MH)
- Presented with BMI 20 -> 15 over 2 years
- Paranoid but organized thinking, tremulous.
- SOB -> ED. New LVEF 20% (from 50%). HR 130-140
- TSH <0.01, T4 normal, T3 > 20 (max of assay). TRAB pending. No visible nodule/goiter.
- “I take water buffalo thyroid”
- “It’s not my heart [making me short of breath]. My heart is more like a conduit than a pump”
- Denies thyrotoxicosis/thyroid storm is problem; declines to take methimazole/PTU. Refuses to see psych.

## Slide outline
### Slide 1
- 56M anesthesiologist (forced leave for MH)
- Presented with BMI 20 -> 15 over 2 years
- Paranoid but organized thinking, tremulous.
- SOB -> ED. New LVEF 20% (from 50%). HR 130-140
- TSH <0.01, T4 normal, T3 > 20 (max of assay). TRAB pending. No visible nodule/goiter.
- “I take water buffalo thyroid”
- “It’s not my heart [making me short of breath]. My heart is more like a conduit than a pump”
- Denies thyrotoxicosis/thyroid storm is problem; declines to take methimazole/PTU. Refuses to see psych.


## Learning objectives
- 56M anesthesiologist (forced leave for MH)
- Presented with BMI 20 -> 15 over 2 years
- Paranoid but organized thinking, tremulous.
- SOB -> ED. New LVEF 20% (from 50%). HR 130-140
- TSH <0.01, T4 normal, T3 > 20 (max of assay). TRAB pending. No visible nodule/goiter.

## Bottom line / summary
- 56M anesthesiologist (forced leave for MH)
- Presented with BMI 20 -> 15 over 2 years
- Paranoid but organized thinking, tremulous.
- SOB -> ED. New LVEF 20% (from 50%). HR 130-140
- TSH <0.01, T4 normal, T3 > 20 (max of assay). TRAB pending. No visible nodule/goiter.

## Approach
1. TODO: Outline the initial assessment or decision point.
2. TODO: Outline the next diagnostic or management step.
3. TODO: Outline follow-up or escalation criteria.

## Red flags / when to escalate
- TODO: List red flags that require urgent escalation.

## Common pitfalls
- TODO: Capture common errors or missed steps.

## References
TODO: Add landmark references or guideline citations.

## Slides and assets
- [Presentations/MM BL 2022-11-9.pptx](../../archive/Presentations/MM%20BL%202022-11-9.pptx)

## Source materials
- [Presentations/MM BL 2022-11-9.pptx](../../archive/Presentations/MM%20BL%202022-11-9.pptx)
